Understanding Prescription Weight Loss Dosing Differences
Wegovy vs Mounjaro Dosage: Core Mechanism Differences
When comparing Wegovy vs Mounjaro dosage schedules, the fundamental difference lies in their mechanisms of action, which directly influences their dosing protocols. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, requiring a carefully structured 16-week escalation programme. Mounjaro utilises tirzepatide, a dual GIP and GLP-1 receptor agonist, following its own distinct dosing pathway designed for its unique dual hormone approach. Both prescription-only medicines require clinical assessment and ongoing prescriber oversight to ensure safe dose progression. Understanding these mechanistic differences helps explain why their dosing schedules cannot be directly interchanged.
The Wegovy vs Mounjaro dosage comparison becomes particularly relevant when considering treatment duration and maintenance phases. Wegovy's escalation follows a proven pathway: 0.25mg for weeks 1-4, progressing through 0.5mg, 1mg, 1.7mg, before reaching the 2.4mg maintenance dose at week 17. Mounjaro follows its own escalation protocol, reaching maintenance doses that reflect its dual receptor mechanism. Both treatments must be used alongside a reduced-calorie diet and increased physical activity, with dosing adjustments only made under prescriber guidance. This structured approach ensures optimal tolerability whilst maximising the therapeutic benefits of each treatment's unique mechanism.
Comprehensive Pricing for Wegovy vs Mounjaro Dosage Options
Our transparent pricing structure for Wegovy vs Mounjaro dosage options reflects the different cost considerations of each treatment pathway. Wegovy single pens start at £79.99 for the 0.25mg starter dose (with code FIRST40), progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. Our Getting Started bundles provide seamless progression: the Intro Duo (0.25mg & 0.5mg) costs £169.99, whilst the Progress Trio covering 12 weeks (0.25mg, 0.5mg & 1mg) is available for £299.99. Each bundle ensures uninterrupted treatment progression without the concern of supply gaps during critical dose escalation phases.
The Wegovy vs Mounjaro dosage cost comparison extends beyond individual pen prices to consider long-term maintenance requirements. Our Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99, offering treatment security once you've reached your optimal Wegovy dose. All pricing includes our prescriber review service, with standard 3-day assessment or express 24-hour options available. New customers apply code FIRST40 at checkout, whilst returning customers use DOSE25 to access these competitive rates. Both discount codes are automatically applied to reach the final prices listed, ensuring complete transparency in your Wegovy vs Mounjaro dosage investment.
Clinical Evidence Supporting Wegovy vs Mounjaro Dosage Protocols
The clinical evidence base supporting Wegovy vs Mounjaro dosage schedules comes from extensive research programmes, with Wegovy's STEP trials demonstrating the effectiveness of its specific dose escalation protocol. In the landmark STEP 1 trial (Wilding et al., NEJM, 2021), participants following Wegovy's structured dosing alongside diet and exercise achieved an average weight reduction of approximately 15% at 68 weeks, compared to 2.4% with placebo. The STEP programme encompassed over 4,500 participants across multiple studies, validating the current dose escalation schedule now used in clinical practice.
When comparing Wegovy vs Mounjaro dosage research, it's important to note that both treatments were studied using their respective optimal dosing protocols, making direct trial comparisons inappropriate due to different study designs and populations. The SELECT cardiovascular outcomes trial demonstrated that Wegovy's 2.4mg maintenance dose achieved a 20% reduction in major cardiovascular events (HR 0.80), highlighting benefits beyond weight management. Both treatments require their specific dose escalation schedules to achieve optimal results whilst minimising side effects, emphasising why prescriber guidance throughout the dosing journey remains essential.
How Wegovy's Dosing Schedule Supports Weight Management
Wegovy's carefully designed dosing schedule works by gradually introducing semaglutide to allow your body to adapt to its GLP-1 receptor agonist effects. Starting with the 0.25mg dose, the medication begins working on brain appetite centres to reduce food cravings and promote feelings of fullness after smaller meals. The 4-week intervals at each dose level allow your digestive system to adjust to the medication's effects on gastric emptying, whilst your appetite regulation mechanisms adapt to the enhanced GLP-1 signalling. This gradual escalation minimises gastrointestinal side effects that might occur with faster dose increases. The 16-week journey to maintenance dosing ensures optimal tolerability whilst building towards maximum therapeutic effect. By week 17, when you reach the 2.4mg maintenance dose, your body has fully adapted to Wegovy's mechanism, allowing for sustained weight management support.
Streamlined Ordering Process for Wegovy vs Mounjaro Dosage Assessment
Our ordering process for Wegovy vs Mounjaro dosage assessment begins with a comprehensive 3-minute online clinical questionnaire designed to evaluate your suitability for prescription weight loss treatments. The assessment covers your BMI, weight-related health conditions, previous weight management attempts, and current medications to ensure safe prescribing practices. Our qualified prescribers review your assessment within 3 working days (or 24 hours with express service), providing detailed guidance on which treatment and dosing schedule best suits your individual circumstances. Once approved, your chosen treatment is dispatched via next-day cold-chain delivery, maintaining the temperature-controlled environment essential for these prescription-only medicines. The entire process, from assessment to delivery, is designed to get you started on your weight management journey with minimal delay whilst maintaining the highest clinical standards.
Storage Advantages in Wegovy vs Mounjaro Dosage Management
Understanding storage requirements forms a practical consideration in Wegovy vs Mounjaro dosage management, particularly for patients with active lifestyles or travel commitments. Wegovy pens can be stored at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This extended temperature stability makes Wegovy particularly suitable for patients who travel frequently or prefer not to carry cooling packs during extended trips. The FlexTouch pen design used for Wegovy delivery provides reliable dose accuracy throughout the escalation schedule, from the initial 0.25mg through to maintenance 2.4mg. All doses should be administered on the same day each week, with the injection site rotated between thigh, abdomen, or upper arm. The 6-week room temperature stability ensures treatment continuity even during extended periods away from refrigeration, supporting adherence throughout the complete dose escalation programme.
Personalised Wegovy vs Mounjaro Dosage Selection Strategy
Developing a personalised approach to Wegovy vs Mounjaro dosage selection requires careful consideration of your individual medical history, lifestyle factors, and treatment goals. Our prescribers evaluate factors such as previous GLP-1 experience, gastrointestinal sensitivity, injection preferences, and specific weight management objectives to recommend the most appropriate treatment pathway. Some patients may benefit from Wegovy's single-hormone GLP-1 approach with its established dose escalation schedule, whilst others might be better suited to Mounjaro's dual-receptor mechanism and corresponding dosing protocol.
The Wegovy vs Mounjaro dosage decision also considers practical factors such as storage requirements, travel patterns, and long-term treatment sustainability. Our clinical team provides ongoing support throughout your chosen treatment journey, with dose adjustment guidance and side effect management strategies tailored to your specific medication pathway. Both treatments are available through our GPhC-registered pharmacy (#9012878), ensuring continuity of care regardless of which option proves most suitable. This personalised approach ensures that your prescription weight loss journey is optimised from the very first injection through to long-term maintenance dosing.
Start Your Prescription Weight Loss Journey Today
Beginning your prescription weight loss journey with either Wegovy or Mounjaro dosage options is straightforward through our comprehensive clinical service. New customers can access our competitive pricing using code FIRST40 at checkout, whilst returning customers benefit from code DOSE25 for continued treatment. Our bundles provide seamless dose progression - from starter combinations through to maintenance supplies - ensuring your treatment pathway remains uninterrupted. Visit https://everydaymeds.co.uk/collections/wegovy to complete your clinical assessment and discover which dosing schedule aligns with your weight management goals. Both Wegovy and Mounjaro represent evidence-based approaches to prescription weight loss, with our expert clinical team available to guide your treatment selection and ongoing care. Take the first step towards medically-supported weight management with our trusted, GPhC-registered pharmacy service.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
